Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Market Cap	522.11M -35.8%
Revenue (ttm)	1.81B -10.7%
Net Income	4.12M -89.6%
EPS	0.01 -89.5%
Shares Out	510.87M
PE Ratio	126.88
Forward PE	n/a
Dividend	0.04 (3.83%)
Ex-Dividend Date	Dec 1, 2025

Volume	21,827
Average Volume	199,632
Open	101.30
Previous Close	101.30
Day's Range	99.90 - 103.50
52-Week Range	91.20 - 159.90
Beta	0.20
RSI	36.62
Earnings Date	Mar 23, 2026

About Novolog (Pharm-Up 1966)

Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Healthcare Services division provides personalized medicine, medical and diagnostic laboratory, and other ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1966
• Employees: 936
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: NVLG

Financial Performance

In 2025, Novolog (Pharm-Up 1966)'s revenue was 1.81 billion, a decrease of -10.70% compared to the previous year's 2.02 billion. Earnings were 4.12 million, a decrease of -89.59%.